90 related articles for article (PubMed ID: 8180600)
1. Shedding of CD9 antigen in acute lymphoblastic leukemia.
Komada Y; Sakurai M
Leuk Lymphoma; 1994 Feb; 12(5-6):365-72. PubMed ID: 8180600
[TBL] [Abstract][Full Text] [Related]
2. Shedding of CD9 antigen by bone marrow cells from patients with acute lymphoblastic leukaemia.
Komada Y; Zhang SL; Zhou YW; Shibata T; Azuma E; Sakurai M
Br J Haematol; 1992 Aug; 81(4):526-9. PubMed ID: 1390240
[TBL] [Abstract][Full Text] [Related]
3. Shedding of CD9 antigen into cerebrospinal fluid by acute lymphoblastic leukemia cells.
Komada Y; Ochiai H; Shimizu K; Azuma E; Kamiya H; Sakurai M
Blood; 1990 Jul; 76(1):112-6. PubMed ID: 2364164
[TBL] [Abstract][Full Text] [Related]
4. CD9 antigen on acute non-lymphoid leukemia cells: preferential expression by promyelocytic (M3) subtype.
Ferrero D; Carlesso N; Gallo E; Pregno P; De Fabritiis P; Petti MC; Mandelli F
Leuk Res; 1991; 15(6):457-61. PubMed ID: 1861531
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody (SJ-9A4) to P24 present on common alls, neuroblastomas and platelets - II. Characterization of P24 and shedding in vitro and in vivo.
Komada Y; Peiper SC; Melvin SL; Tarnowski B; Green AA
Leuk Res; 1983; 7(4):499-507. PubMed ID: 6578391
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD9 antigen on normal activated human B cells.
Zeleznik-Le NJ; Metzgar RS
Cell Immunol; 1989 Oct; 123(1):70-82. PubMed ID: 2673548
[TBL] [Abstract][Full Text] [Related]
7. CD9 is an unreliable antibody for bone marrow purging.
Fort JA; Rios AM; Gross S; Janssen WE
Prog Clin Biol Res; 1990; 333():185-9. PubMed ID: 2408060
[TBL] [Abstract][Full Text] [Related]
8. Homotypic aggregation of pre-B leukemic cell lines by antibodies to VLA integrins correlates with their expression of CD9.
Letarte M; Seehafer JG; Greaves A; Masellis-Smith A; Shaw AR
Leukemia; 1993 Jan; 7(1):93-103. PubMed ID: 7678118
[TBL] [Abstract][Full Text] [Related]
9. Distribution of cell surface glycoprotein CD9 (P24) antigen on megakaryocyte lineage leukemias and cell lines.
Imamura N; Mtasiwa DM; Ota H; Inada T; Kuramoto A
Am J Hematol; 1990 Sep; 35(1):65-7. PubMed ID: 2389771
[TBL] [Abstract][Full Text] [Related]
10. Characterization of rat NCA/CD9 cell surface antigen and its expression by normal and malignant neural cells.
Deissler H; Blass-Kampmann S; Kindler-Röhrborn A; Meyer HE; Rajewsky MF
J Neurosci Res; 1996 Mar; 43(6):664-74. PubMed ID: 8984196
[TBL] [Abstract][Full Text] [Related]
11. CD9 blockade suppresses disease progression of high-risk pediatric B-cell precursor acute lymphoblastic leukemia and enhances chemosensitivity.
Leung KT; Zhang C; Chan KYY; Li K; Cheung JTK; Ng MHL; Zhang XB; Sit T; Lee WYW; Kang W; To KF; Yu JWS; Man TKF; Wang H; Tsang KS; Cheng FWT; Lam GKS; Chow TW; Leung AWK; Leung TF; Yuen PMP; Ng PC; Li CK
Leukemia; 2020 Mar; 34(3):709-720. PubMed ID: 31624373
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD9 (p24) antigen on hematopoietic cells following treatment with phorbol ester.
Yasukawa M; Hato T; Inatsuki A; Kobayashi Y
Acta Haematol; 1988; 79(3):133-6. PubMed ID: 3128036
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of the mouse equivalent of CD9 antigen.
Rubinstein E; Billard M; Plaisance S; Prenant M; Boucheix C
Thromb Res; 1993 Sep; 71(5):377-83. PubMed ID: 8236164
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia.
Yamazaki H; Xu CW; Naito M; Nishida H; Okamoto T; Ghani FI; Iwata S; Inukai T; Sugita K; Morimoto C
Biochem Biophys Res Commun; 2011 May; 409(1):14-21. PubMed ID: 21549094
[TBL] [Abstract][Full Text] [Related]
15. [Expression of AC133 vs. CD34 in acute childhood leukemias].
Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of 9-O-acetylated sialoglycoproteins from leukemic cells and their potential as immunological tool for monitoring childhood acute lymphoblastic leukemia.
Pal S; Ghosh S; Mandal C; Kohla G; Brossmer R; Isecke R; Merling A; Schauer R; Schwartz-Albiez R; Bhattacharya DK; Mandal C
Glycobiology; 2004 Oct; 14(10):859-70. PubMed ID: 15190007
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
[TBL] [Abstract][Full Text] [Related]
18. CD99 (p30/32MIC2) immunoreactivity in the diagnosis of leukemia cutis.
Dorfman DM; Kraus M; Perez-Atayde AR; Barnhill RL; Pinkus GS; Granter SR
Mod Pathol; 1997 Apr; 10(4):283-8. PubMed ID: 9110288
[TBL] [Abstract][Full Text] [Related]
19. CD9 expression indicates a poor outcome in acute lymphoblastic leukemia.
Liang P; Miao M; Liu Z; Wang H; Jiang W; Ma S; Li C; Hu R
Cancer Biomark; 2018; 21(4):781-786. PubMed ID: 29286918
[TBL] [Abstract][Full Text] [Related]
20. Preparation of fibroblast-free cytotrophoblast cultures utilizing differential expression of the CD9 antigen.
Morrish DW; Shaw AR; Seehafer J; Bhardwaj D; Paras MT
In Vitro Cell Dev Biol; 1991 Apr; 27A(4):303-6. PubMed ID: 1856155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
